Stockscreener 앱 받기
63.53
1.11%
0.695
시장 영업 전:
64.85
1.315
+2.07%
Kiniksa Pharmaceuticals International Plc 주식(KNSA)의 최신 뉴스
Kiniksa Pharmaceuticals International PLC (KNSA) Cash Flow - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Q2 2026: Everyt - GuruFocus
Kiniksa Pharmaceuticals (NASDAQ:KNSA): A High-Growth Stock with Strong Technical Setup - ChartMill
KNSA|Kiniksa Pharmaceuticals International PLC|Price:62.840|Chg%:-0.210 - TradingKey
Kiniksa Pharmaceuticals International PLC - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TradingKey - TradingKey
Granahan Investment Management LLC Cuts Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Spruce Street Capital LP Has $36.65 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc Revenue Breakdown – NASDAQ:KNSA - TradingView
Zacks.com featured highlights include American Outdoor Brands, Cimpress, National Energy Services Reunited, CTO Realty Growth and Kiniksa Pharmaceuticals International - The Globe and Mail
Kiniksa Pharmaceuticals International, PLC expected to post earnings of 30 cents a shareEarnings Preview - TradingView
Kiniksa Pharmaceuticals (NASDAQ:KNSA): A High Growth Momentum Stock With a Breakout Setup - ChartMill
Kiniksa Pharmaceuticals to report Q2 2026 results in conference call and webcast - Bitget
Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026 - The Manila Times
Kiniksa to discuss portfolio execution in July 28 webcast - Stock Titan
KNSA Maintained by Goldman Sachs -- Price Target Raised to $75 - GuruFocus
5 Stocks With Recent Price Strength Despite Recent Market Volatility - TradingView
Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here's Why - Yahoo Finance
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Qualifies as an Affordable Growth Stock With Strong Revenue and Earnings Momentum - ChartMill
Kiniksa Pharmaceuticals International, plc (KNSA) is a great choice for 'trend' investors, here's why - MSN
Kiniksa Pharmaceuticals International PLC (KNSA) Shares Surge 4. - GuruFocus
Dhiraj H Malkani Net Worth (2026) - GuruFocus
Price to sales forward of Kiniksa Pharmaceuticals International, plc – NASDAQ:KNSA - TradingView
Price to book forward of Kiniksa Pharmaceuticals International, plc – NASDAQ:KNSA - TradingView
Kiniksa Pharmaceuticals Leads Small-Cap Stocks with 119.62% Return - MarketsMojo
Kiniksa Pharmaceuticals: Leader In Pericarditis Merits Hold Rating After Recent Gains - Seeking Alpha
KNSA Maintained by Wells Fargo -- Price Target Raised to $74.00 - GuruFocus
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Kiniksa Pharmaceuticals International, plc (KNSA) surges 5.4%: Is this an indication of further gains? - MSN
Kiniksa Pharmaceuticals International (KNSA) Joins Russell Indexes, Is The Upside Already Priced In? - Yahoo Finance
Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Kiniksa Pharmaceuticals International PLC (KNSA) Shares Surge 7. - GuruFocus
Will Broad Russell Index Inclusion Reshape Kiniksa Pharmaceuticals' (KNSA) ARCALYST-Centered Growth Narrative? - simplywall.st
Performance share awards at Kiniksa (NASDAQ: KNSA) tied to KPL-387 FDA goals - Stock Titan
Kiniksa (KNSA) Chief Strategy Officer named as insider in Form 3 - Stock Titan
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month HighHere's What Happened - MarketBeat
Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Kiniksa Pharmaceuticals Q1 2026 Earnings: Strong EPS Beat Drives Stock HigherTrough Earnings Signal - DonanımHaber
Here's why you should add Kiniksa stock to your portfolio now - MSN
What makes Kiniksa Pharmaceuticals International, plc (KNSA) a strong momentum stock: Buy now? - MSN
Kiniksa Pharmaceuticals Hits New 52-Week High of USD 59.89 - MarketsMojo
Kiniksa Pharmaceuticals Hits New 52-Week High of USD 63.77 - MarketsMojo
Peregrine Capital Management LLC Sells 29,550 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Inspire Investing LLC Makes New $1.70 Million Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Pictet Asset Management Holding SA Sells 164,232 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
What Makes Kiniksa Pharmaceuticals International, plc (KNSA) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gains? - Yahoo Finance
KNSA Q1 2026 Earnings: EPS Surpasses Estimates Reflecting Strong Operational PerformanceTrough Earnings Signal - dars.gov.et
AMI Asset Management Corp Has $1.06 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International PLC (KNSA) Shares Surge 5. - GuruFocus
KNSA Maintained by Wedbush -- Price Target Raised to $72.00 - GuruFocus
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell 2500 Growth Benchmark - marketscreener.com
Kiniksa Pharmaceuticals International, plc(NasdaqGS: KNSA) added to Russell 2000 Index - marketscreener.com
0.30%
2.01%
자본화:
|
볼륨(24시간):